Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Shares Outstanding (2016 - 2025)

Mimedx (MDXG) has disclosed Shares Outstanding for 15 consecutive years, with $148.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 0.79% to $148.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $148.1 million through Dec 2025, up 0.79% year-over-year, with the annual reading at $148.1 million for FY2025, 0.79% up from the prior year.
  • Shares Outstanding hit $148.1 million in Q4 2025 for Mimedx, roughly flat from $148.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $148.1 million in Q4 2025 to a low of $1.1 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $123.4 million across 5 years, with a median of $116.2 million in 2023.
  • Biggest five-year swings in Shares Outstanding: crashed 49.92% in 2021 and later surged 10379.6% in 2022.
  • Year by year, Shares Outstanding stood at $112.7 million in 2021, then rose by 0.89% to $113.7 million in 2022, then increased by 28.6% to $146.2 million in 2023, then increased by 0.48% to $146.9 million in 2024, then grew by 0.79% to $148.1 million in 2025.
  • Business Quant data shows Shares Outstanding for MDXG at $148.1 million in Q4 2025, $148.1 million in Q3 2025, and $147.9 million in Q2 2025.